Pharmaceutical takeover: Biontech makes exchange offer to Curevac shareholders:
In June, the Mainz-based biopharmaceutical | and vaccine company Biontech ...
allgemeine-zeitung.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/biontech-macht-curevac-aktionaeren-umtausch-angebot-5089608
Story Details
| Last Updated | |
| Total Articles | 4 |
Main Topics
single unit of ownership in a corporation, mutual fund, or any other organization
News on this topic
Share swap - | Biontech launches offer to Curevac shareholders: The deadline for the share swap is December 3rd. The former competitors plan to conduct joint ...
stuttgarter-nachrichten.de/inhalt.aktientausch-biontech-startet-angebot-an-curevac-aktionaere.9753c233-bf64-4877-8fed-36fe7b77f02d.html
Pharmaceutical takeover: Biontech makes exchange offer to Curevac shareholders: In June, the Mainz-based biopharmaceutical | and vaccine company Biontech ...
echo-online.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/biontech-macht-curevac-aktionaeren-umtausch-angebot-5089608
Pharmaceutical takeover: Biontech makes exchange offer to Curevac shareholders: In June, the Mainz-based biopharmaceutical | and vaccine company Biontech ...
wiesbadener-kurier.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/biontech-macht-curevac-aktionaeren-umtausch-angebot-5089608
Similar to This
Previous
Exclusive: The BioNTech closures leave the German government in Berlin unmoved: Until now, it was not known how the German government felt about the BioNTech ...
allgemeine-zeitung.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/exklusiv-biontech-schliessungen-lassen-bundesregierung-kalt-6549007
Multi-million euro offer for plant in Tübingen: 500 CureVac employees to be taken on
swp.de/lokales/tuebingen/millionenangebot-fuer-werk-in-tuebingen-500-mitarbeiter-von-curevac-sollten-uebernommen-werden-79573804.html
Film about Ingmar Hoerr and CureVac in Tübingen: Saving the world in a flash: A biopic about mRNA pioneer and CureVac founder Ingmar Hoerr premieres at the Hof ...
swp.de/lokales/tuebingen/kultur-tuebingen/film-ueber-curevac-in-tuebingen-mal-eben-kurz-die-welt-retten-79556685.html
Paid articlePaywall OpinionMillion-dollar bonuses: Boris Palmer rants: Payments to CureVac manager "outrageous"
stuttgarter-nachrichten.de/wirtschaft/millionen-boni-boris-palmer-empoerend-hohe-zahlungen-an-curevac-manager-79539819.html
BioNTech: Three German sites are closing their plants: No buyer has been found for the plants in Idar-Oberstein, Marburg, and Tübingen. BioNTech has announced ...
handelsblatt.com/unternehmen/industrie/biontech-drei-deutsche-standorte-schliessen-ihre-werke/100257969.html
Paid articlePaywallKey FactsBiontech announces closure of three sites from 2027
Sep 29, 2026 · Reading time: ~30 sec.
Summary created with AI assistance · Source: handelsblatt.com
Summary created with AI assistance · Source: handelsblatt.com
- The closures are scheduled for Tübingen in late 2027, Marburg in early 2028 and Idar-Oberstein in late 2028.
- According to the company, the decision affects about 1,800 employees, nearly one-quarter of Biontech’s workforce.
- Biontech attributed the failed months-long search mainly to difficult market and investment conditions.
- Biontech agreed additional severance terms with the group works council, but initially disclosed no details.
Exclusive: Federal government wants to sell off all BioNTech shares it holds: Since BioNTech acquired CureVac, the federal government has held shares in the ...
allgemeine-zeitung.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/exklusiv-bundesregierung-stoesst-alle-biontech-aktien-ab-6476398
Paid articlePaywall
CureVac in Tübingen: Takeover by BioNTech and sites in danger: BioNTech acquired CureVac for $1.25 billion at the end of last year and will now close all CureVac ...
sueddeutsche.de/wirtschaft/ugur-sahin-oezlem-tuereci-ingmar-hoerr-struengmann-mrna-impfstoffe-mrna-krebs-moderna-li.3522088
Paid articlePaywallWill the Tübingen site be completely closed?: Clarity on BioNTech locations by the end of September
swp.de/lokales/tuebingen/tuebinger-standort-bedroht-klarheit-ueber-biontech-standorte-bis-ende-september-79418978.html
CureVac exit threatens Tübingen as a research location - | Tübingen district - | Reutlinger General-Anzeiger - | gea.de
gea.de/neckar-alb/kreis-tuebingen_artikel,-curevac-aus-bedroht-t%C3%BCbingen-als-forschungsstandort-_arid,7153598.html
Pharmaceutical industry: CureVac founder accuses BioNTech of deception: Shortly after the acquisition, BioNTech announced the closure of CureVac's former ...
zeit.de/wirtschaft/unternehmen/2026-05/curevec-gruender-vorwurf-taeuschung-biontech
Bayer Group surprisingly sues Mainz-based BioNTech - | here's the background: No sooner has the patent dispute with CureVac been settled through the takeover ...
mittelhessen.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/bayer-verklagt-ueberraschend-biontech-was-ist-da-los-5297243
Paid articlePaywall Biotech: BioNTech finalizes CureVac acquisition: The merger of the two vaccine developers is complete. BioNTech is acquiring its competitor CureVac - | and thus ...
handelsblatt.com/unternehmen/industrie/biotech-biontech-macht-uebernahme-von-curevac-perfekt/100185010.html
BioNTech stock: Hope is back: BioNTech acquires CureVac and strengthens market position; blockbuster potential for new cancer drug BNT327.
boerse-online.de/nachrichten/aktien/biontech-aktie-die-hoffnung-ist-zurueck-20392023.html
80 percent of shares acquired: CureVac billion-euro deal with BioNTech close to completion
swp.de/lokales/tuebingen/80-prozent-der-aktien-uebernommen-curevac-milliarden-deal-mit-biontech-kurz-vor-abschluss-78493611.html
BioNTech launches major video campaign for at-risk groups regarding COVID-19 vaccination
mittelhessen.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/biontech-faehrt-grosse-video-kampagne-zu-corona-impfung-5111619
Paid articlePaywall
Antitrust authority approves BioNTech's acquisition of CureVac: Why do competition watchdogs see no threat to innovation in the merger between BioNTech and ...
giessener-allgemeine.de/wirtschaft/kartellamt-erlaubt-kauf-von-curevac-durch-biontech-zr-93985421.html
Curevac and Biontech end dispute: Agreement thanks to takeover: Curevac and its partner GSK will receive a total of 740 million euros for the rights to Covid-19 ...
swp.de/lokales/tuebingen/curevac-und-biontech-beenden-streit-einigung-dank-uebernahme-78234691.html
Paid articlePaywall Pharma industry: Biontech halves loss - cancer strategy picks up speed: Biontech more than doubled its turnover in the second quarter. The company plans to spend ...
handelsblatt.com/unternehmen/industrie/pharmaindustrie-biontech-halbiert-verlust-krebsstrategie-nimmt-fahrt-auf/100146054.html
Key FactsBiontech Boosts Growth with Cancer Strategy and Deals
Aug 4, 2025 · Reading time: ~45 sec.
Summary created with AI assistance · Source: handelsblatt.com
Summary created with AI assistance · Source: handelsblatt.com
- Biontech doubled its revenue to €260.8 million in Q2 and reduced its net loss to €386.6 million.
- The company is refocusing on oncology, strengthened by a partnership with Bristol Myers Squibb and the planned acquisition of Curevac.
- Over 20 studies involving BNT327 across various tumors are underway, with a pivotal breast cancer phase-3 study starting this year.
- Revenue is forecasted to decline in 2025 while R&D spending is expected to increase to as much as €2.8 billion.
We continue to invest significantly in the implementation of our strategy, and our operational and financial measures are showing initial tangible results.— CFO Ramón Zapata discusses Biontech's progress in cancer research.
Biontech swallows Curevac: A billionaire paves the way: No question: Biontech has pulled off a coup with the takeover of Curevac. But what prompted Curevac to ...
mittelhessen.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/biontech-schluckt-curevac-ein-milliardaer-macht-den-weg-frei-4722890
Paid articlePaywallKey FactsBiontech Acquires Curevac with Billionaire Support
Jun 18, 2025 · Reading time: ~45 sec.
Summary created with AI assistance · Source: mittelhessen.de
Summary created with AI assistance · Source: mittelhessen.de
- Biontech finalized the acquisition of Curevac in June 2025, expanding its capabilities in RNA technology.
- SAP billionaire Dietmar Hopp holds over one-third of Curevac shares through investment firms, facilitating the transaction.
- The takeover is viewed by Biontech as a key element in enhancing its oncology strategy and future cancer therapies.
- Curevac founder Ingmar Hoerr expressed regret that the Curevac brand will disappear following the acquisition.
This transaction is another building block in Biontech's oncology strategy and an investment in the future of cancer medicine.— Ugur Sahin, CEO and co-founder of Biontech, discussing the significance of the acquisition of Curevac.
Breaking news: Biontech plans to take over German competitor Curevac: The pharmaceutical company Biontech is planning to take over its German competitor Curevac ...
n-tv.de/newsletter/breakingnews/Biontech-will-deutschen-Konkurrenten-Curevac-uebernehmen-article25829589.html
Key FactsBiontech Expands Through Curevac Acquisition
Jun 12, 2025 · Reading time: ~45 sec.
Summary created with AI assistance · Source: sueddeutsche.de
Summary created with AI assistance · Source: sueddeutsche.de
- Biontech is acquiring Curevac for approximately $1.25 billion to accelerate innovative cancer therapy research.
- The deal ends a long-standing rivalry peaked during the Covid-19 vaccine race between the two companies.
- The transaction is structured as a stock swap, granting Curevac shareholders four to six percent ownership in Biontech.
- Germany’s government views the acquisition favorably, highlighting the creation of a leading national biotech company.
We want to bring together complementary skills and technologies.— Uğur Şahin, co-founder and CEO of Biontech, discusses the goals of the acquisition of Curevac.
Next